These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1320971)

  • 1. The relationship between craving, anxiety, and other symptoms in opioid withdrawal.
    Swift RM; Stout RL
    J Subst Abuse; 1992; 4(1):19-26. PubMed ID: 1320971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Craving and drug reward: a comparison of methadone and clonidine in detoxifying opiate addicts.
    Dawe S; Gray JA
    Drug Alcohol Depend; 1995 Oct; 39(3):207-12. PubMed ID: 8556969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of opioid craving over time as measured by visual analog scales.
    McMillan DE; Gilmore-Thomas K
    Drug Alcohol Depend; 1996 Mar; 40(3):235-9. PubMed ID: 8861402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Craving despite extremely high methadone dosage.
    de Vos JW; Ufkes JG; van Brussel GH; van den Brink W
    Drug Alcohol Depend; 1996 Mar; 40(3):181-4. PubMed ID: 8861396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Withdrawal and Craving Scores in Participants Undergoing Opioid Detoxification Utilizing Ibogaine.
    Malcolm BJ; Polanco M; Barsuglia JP
    J Psychoactive Drugs; 2018; 50(3):256-265. PubMed ID: 29608409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gradual dose taper following chronic buprenorphine.
    Becker AB; Strain EC; Bigelow GE; Stitzer ML; Johnson RE
    Am J Addict; 2001; 10(2):111-21. PubMed ID: 11444154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxone-induced withdrawal in patients with buprenorphine dependence.
    Nigam AK; Srivastava RP; Saxena S; Chavan BS; Sundaram KR
    Addiction; 1994 Mar; 89(3):317-20. PubMed ID: 8173501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pupillometric changes during gradual opiate detoxification correlate with changes in symptoms of opiate withdrawal as measured by the Weak Opiate Withdrawal Scale.
    Rosse RB; Johri S; Goel M; Rahman F; Jawor KA; Deutsch SI
    Clin Neuropharmacol; 1998; 21(5):312-5. PubMed ID: 9789712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single high-dose buprenorphine for opioid craving during withdrawal.
    Ahmadi J; Jahromi MS; Ghahremani D; London ED
    Trials; 2018 Dec; 19(1):675. PubMed ID: 30526648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone and lofexidine combination treatment compared with conventional lofexidine treatment for in-patient opiate detoxification.
    Buntwal N; Bearn J; Gossop M; Strang J
    Drug Alcohol Depend; 2000 May; 59(2):183-8. PubMed ID: 10891632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid effects and opioid withdrawal during a 24 h dosing interval in patients maintained on buprenorphine.
    Lopatko OV; White JM; Huber A; Ling W
    Drug Alcohol Depend; 2003 Apr; 69(3):317-22. PubMed ID: 12633918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low efficacy of non-opioid drugs in opioid withdrawal symptoms.
    Hermann D; Klages E; Welzel H; Mann K; Croissant B
    Addict Biol; 2005 Jun; 10(2):165-9. PubMed ID: 16191669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the effects of lofexidine and clonidine on naloxone-precipitated withdrawal in opioid-dependent humans.
    Walsh SL; Strain EC; Bigelow GE
    Addiction; 2003 Apr; 98(4):427-39. PubMed ID: 12653813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids.
    Cheskin LJ; Fudala PJ; Johnson RE
    Drug Alcohol Depend; 1994 Oct; 36(2):115-21. PubMed ID: 7851278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clonidine in opiate withdrawal. III. Pros and cons of administration].
    Keup W
    MMW Munch Med Wochenschr; 1982 Feb; 124(7):156-8. PubMed ID: 6801496
    [No Abstract]   [Full Text] [Related]  

  • 16. A protocol to switch high-dose, methadone-maintained subjects to buprenorphine.
    Levin FR; Fischman MW; Connerney I; Foltin RW
    Am J Addict; 1997; 6(2):105-16. PubMed ID: 9134072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mr R: a case study of withdrawal.
    Dennison SJ
    Behav Med; 1992; 18(3):139-40. PubMed ID: 1330103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of acetorphan with clonidine for opiate withdrawal symptoms.
    Hartmann F; Poirier MF; Bourdel MC; Loo H; Lecomte JM; Schwartz JC
    Am J Psychiatry; 1991 May; 148(5):627-9. PubMed ID: 2018165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of clonidine and morphine on opioid withdrawal in rhesus monkeys.
    Katz JL
    Psychopharmacology (Berl); 1986; 88(3):392-7. PubMed ID: 3083461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clonidine in opiate withdrawal. II. Potential side-effects].
    Keup W
    MMW Munch Med Wochenschr; 1982 Feb; 124(7):153-5. PubMed ID: 6801495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.